Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics

NCT05378282 is registered in ClinicalTrials.gov with Hospital Juarez de Mexico as lead sponsor.

NCT NCT05378282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Lead sponsor
Hospital Juarez de Mexico
Phase
Observational
Overall status
Completed
Start date
September 3, 2021
Completion date
February 28, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes, type 2 diabetes with renal manifestations